The State of Texas Top Legal Officer Takes Legal Action Against Acetaminophen Makers Over Autism Spectrum Allegations

The top legal official in Texas Ken Paxton is taking legal action against the makers of Tylenol, alleging the firms concealed potential risks that the drug posed to children's cognitive development.

The lawsuit follows four weeks after President Donald Trump advocated an unverified association between using Tylenol - referred to as paracetamol - during pregnancy and autism spectrum disorder in offspring.

The attorney general is suing the pharmaceutical giant, which formerly manufactured the drug, the exclusive pain medication recommended for expectant mothers, and Kenvue, which now manufacturers it.

In a statement, he claimed they "betrayed America by profiting off of discomfort and promoting medication regardless of the dangers."

The manufacturer asserts there is no credible evidence connecting Tylenol to autism spectrum disorder.

"These corporations lied for decades, deliberately risking numerous people to line their pockets," the attorney general, from the Republican party, stated.

The company said in a statement that it was "very worried by the perpetuation of misinformation on the safety of acetaminophen and the likely effects that could have on the well-being of women and children in America."

On its official site, Kenvue also mentioned it had "regularly reviewed the applicable studies and there is lacking reliable evidence that indicates a established connection between using acetaminophen and autism."

Associations acting on behalf of physicians and health professionals concur.

The leading OB-GYN organization has said paracetamol - the key substance in acetaminophen - is among limited choices for women during pregnancy to treat pain and elevated temperature, which can present major wellness concerns if ignored.

"In over twenty years of investigation on the use of acetaminophen in gestation, no reliable research has successfully concluded that the use of acetaminophen in any stage of pregnancy causes neurodevelopmental disorders in offspring," the organization said.

The lawsuit references current declarations from the Trump administration in asserting the drug is potentially dangerous.

Recently, the former president raised alarms from medical authorities when he told women during pregnancy to "struggle intensely" not to use acetaminophen when unwell.

The US Food and Drug Administration then issued a notice that medical professionals should consider limiting the use of acetaminophen, while also mentioning that "a causal relationship" between the medication and autism in young ones has not been proven.

Health Secretary Kennedy, who supervises the FDA, had pledged in spring to conduct "a massive testing and research effort" that would identify the cause of autism in a limited time.

But specialists advised that discovering a unique factor of autism - believed by scientists to be the result of a complicated interplay of genetic and environmental factors - would prove challenging.

Autism spectrum disorder is a category of enduring cognitive variation and condition that influences how people experience and engage with the surroundings, and is diagnosed using medical professional evaluations.

In his lawsuit, Paxton - a Trump ally who is campaigning for the Senate - alleges the manufacturer and Johnson & Johnson "intentionally overlooked and sought to suppress the evidence" around acetaminophen and autism.

The case attempts to require the corporations "destroy any promotional materials" that asserts Tylenol is secure for pregnant women.

This legal action mirrors the grievances of a collection of mothers and fathers of young ones with autism spectrum disorder and ADHD who sued the makers of Tylenol in 2022.

The court dismissed the case, stating studies from the parents' expert witnesses was not conclusive.